abstract: Uterine fibroids are the most common gynecological tumors affecting women in their reproductive age. Despite this high incidence the pathogenesis of fibroids is widely unsolved. Whereas formerly only imbalances in hormonal levels were considered to account for tumor development, the identification of genetic changes likely to affect myometrial stem cell reservoirs provided a novel approach to fibroid genesis. Here, we identified a certain subset of cells by the surface marker CD24 with increased abundance in fibroids compared with myometrial tissue. Fibroid cells expressing CD24 shared certain features of immature or progenitor-like cells such as quiescence, reduced expression of smooth muscle differentiation markers and elevated expression of genes involved in the wingless-type (WNT)-pathway such as beta-catenin. In addition, a positive correlation between CD24 and wingless-type family member 4 (WNT4) expression was observed in uterine fibroids with mediator subcomplex 12 gene (MED12) mutations. Our findings suggest that cells highly expressing CD24 represent a type of immature smooth muscle progenitor cells. Their accumulation might be driven by disturbed differentiation processes caused by genetic changes possibly involving MED12 mutations or high mobility group AT-hook (HMGA)2 rearrangements.
Introduction
Uterine fibroids are a common heath issue of women in their reproductive age, with incidences reported from 30-70% (Day Baird et al., 2003; Zimmermann et al., 2012) . Although fibroids are of benign nature, they often cause symptoms such as infertility, recurrent miscarriage and extensive bleeding. First demonstrated based on their unique isoenzyme pattern (Townsend et al., 1970) and X-inactivation studies (Canevari et al., 2005; Cai et al., 2007; Mashal et al., 1994) , a clonal origin of fibroids was reported recently by a more sensitive and reliable method conducted by Holdsworth-Carson et al. (2013) . Hence, it could be considered that fibroids arise from a single mutated cell likely having stem/ progenitor cell characteristics. To date the exact subpopulation of cells giving rise to fibroids is still unknown.
Somatic stem cells are believed to reside in tissues mostly in a dormant or quiescent state and divide upon activation to maintain tissues homeostasis (Reya et al., 2001; Gargett et al., 2007) . This property has been utilized to identify potential stem cells in myometrium or endometrium through their ability to retain proliferation labels such as 5-bromo-2 ′ -deoxyuridine or 3 H-thymidin thus marking non-proliferative cells (Cervello et al., 2007; Szotek et al., 2007) . At present, many types of these stem cells can be prospectively identified in various tissues by a panel of surface markers correlating with stem cell phenotypes (Reya et al., 2001; Dominici et al., 2006; Gargett et al., 2007) . However, exact immunophenotypes especially for uterine stem cells are not yet established (Gargett et al., 2007) . Where an unequivocal immunophenotype is missing, stem/progenitor cells can alternatively be identified by their ability to extrude the DNA-binding dye Hoechst 33342. These so-called side population (SP) cells-named after their appearance in flow cytometric dot blots-overexpress the ATP-binding cassette transporter G2 which is responsible for the removal of uptaken Hoechst 33342. First described for bone marrow (Goodell et al., 2005) , this technique was also adopted to isolate stem/progenitor cells from various other normal tissues (Zuk et al., 2002; Goodell et al., 2005; Goodell, 2005) such as endometrium (Cervelló et al., 2010; Masuda et al., 2010) or different malignancies Wu et al., 2007) . Recently, subpopulations with SP phenotype were isolated from myometrium and fibroid tissue (Ono et al., 2007 (Ono et al., , 2012 Mas et al., 2012) . In this latter case, they may represent a transformed type of uterine stem or precursor cells likely to represent a tumor-initiating subpopulation (Mas et al., 2012) . The exact mechanism † Authors share equal senior authorship.
of this initiation remains mainly unsolved but a recent study points to an indirect paracrine activation of SP cells by smooth muscle cells (Ono et al., 2013) . While the SP detection is a favorable method for isolation of cells with stem cell characteristics, an independent surface marker for fibroid or myometrial progenitors has not been published to date. CD24 is a highly glycosylated anchor protein commonly present on immature cells such as pre-B-cells, muscle stem/satellite cells (Figarella-Branger et al., 1993; Higuchi et al., 1999) , neuronal (Poncet et al., 1996) and hepatic precursors (Qiu et al., 2011) or intestinal (von Furstenberg et al., 2011) and adipose (Rodeheffer et al., 2008) stem cells. Since knockout mice are viable without any obvious defects apart from a reduced number of pre-B-lymphocytes CD24 is considered to be mostly a redundant co-stimulatory molecule during B-cell development (Schabath et al., 2006; Fang et al., 2010) and dampener of inflammation (Chen et al., 2009) . In pathophysiological conditions, CD24 was identified on various cancer entities, e.g. breast, prostate, ovary, lung (small cell and non-small cell) and colon cancer (Kristiansen et al., 2002 (Kristiansen et al., , 2003a 2004a , b, 2005 . The expression of CD24 in most of these neoplasms is correlated with poor prognosis and its expression is believed to augment metastasis by interactions with P-selectin (Aigner et al., 1998; Friederichs et al., 2000; Lim, 2005) . The study presented here is addressing the expression of CD24 in fibroids. In a previous set of experiments (data unpublished), we observed a significantly higher expression in fibroids compared with myometrial tissue confirming earlier results by various other groups (for review see by Arslan et al., 2005) . The preferential expression of CD24 on immature cells in other organs (Fang et al., 2010) and the increasing body of evidence that uterine stem cells, e.g. observed in form of SP cells, might play a pivotal role in fibroid growth (Ono et al., 2007 (Ono et al., , 2012 (Ono et al., , 2013 ) encouraged us to investigate if differences in CD24 expression reflect differences in cell composition. Increased CD24 expression in fibroids may reflect an accumulation of less differentiated CD24 hi cells underpinning a possible role of a stem cell driven pathogenesis of uterine fibroids.
Material and Methods

Ethics statement and tissue sampling
Fibroid specimens were obtained from patients undergoing myomectomy or hysterectomy. All donors were premenopausal and patients with hormonal or immunomodulatory therapies as well as known gynecological comorbidities or malignancies were excluded. Informed written consent was obtained prior to surgery in accordance with the ethics committee vote of the hospitals (Klinikum MIC, Berlin, Germany, Ethics authorization number ETH-08/ 10-01; Klinikum Auguste-Viktoria, Berlin, Germany, Ethics authorization number Eth-07/1001; Charité Campus Benjamin-Franklin, Berlin, Germany, Ethics authorization number EA1/135/2012). Tissue was transferred to chilled Viaspan organ conservation buffer (Bristol-Myers Squibb, Dublin, Ireland) and used for experiments within 24 h. Fresh-frozen tissue for mutational analysis was from the archives of two of the authors (D.N.M. and J.B.). Sampling was approved by the local ethics committee, and before surgery informed written consent was obtained from all patients. In addition, all samples were taken initially for diagnostic purposes and de-identified before their use in study following the rules of Helinski declaration.
Primary cell isolation and cell culture
Primary cells were isolated as described previously (Markowski et al., 2010; Drosch et al., 2013) . After disaggregation, cells were washed with phosphate-buffered saline (PBS) and cultured in medium 199 (Pan Biotech, Aidenbach, Germany) supplemented with 20% fetal bovine serum and 'antibiotic -antimycotic' (Invitrogen, Karlsruhe, Germany), alternatively cells were used for fluorescence-activated cell sorting (FACS) or in vivo transplantation.
Generation of xenografts
Mice were kept in transparent Macrolone TM cages in a light/dark cycle of 12 h/12 h under pathogen-free conditions in the animal facility of Bayer Pharma AG, Berlin, Germany. All experiments were performed in strict compliance with company, regional and federal guidelines for the use of laboratory animals. The study was approved by the Office for Health and Social Affairs Berlin and the company review board, and all efforts were made to minimize animals' stress. Xenografts were established from dissociated fibroids (n ¼ 4) using three to five animal per tumor (dependent on cell yield). Grafting procedures was performed as described previously (Drosch et al., 2013) . In brief, 3 × 10 6 disaggregated tumor cells were resuspended in 100 ml matrigel supplemented with basic fibroblast growth factor, epidermal growth factor and insulin and injected subcutaneously in the 'posterior lateral' aspect of the trunk (lumbar region) of hormone-supplemented ovariectomized 6 -9-week-old scid/bg mice (Taconic, Cologne, Germany). Animals were monitored twice a week and tumor volume was assessed but remained low as reported before (Drosch et al., 2013) . For tumor excision animals were sacrificed by cervical dislocation. Excised tumors were either prepared for cryosectioning by immersing in polyvinyl cryoembedding medium (OCT) (Leica Microsystems, Wetzlar, Germany) or fixed with neutral buffered formalin and subjected to paraffin embedding.
Cell sorting and flow cytometric analysis
Cells were sorted using a FACSAria I special sorting system w (BD Bioscience, Heidelberg, Germany) equipped with three lasers (405, 488 and 630 nm) and analyzed using the FlowJo Software (Tree Star, Ahsland, USA). For sorting dissociated cells from fibroid (n ¼ 9) or myometrial (n ¼ 4) tissue were washed with Hank's balanced salt solution (HBSS) and resuspended in chilled staining buffer [Ca 2+ and Mg 2+ free HBSS containing 1% bovine serum albumin, 10 mM 2-(4-(2-Hydroxyethyl)-1-piperazinyl)-ethan-sulfon acid (HEPES) and antibiotic -antimycotic mixture] and stained with antibodies listed in Table I for 20 min at 48C. Afterwards cells were washed with an excess of staining buffer, resuspended at a concentration of 10 7 cells/ml and subjected to the sorting system. Compensation was performed with single stained and isotype controls. Dead cells were discriminated by staining with 1 mg/ml 4 ′ ,6-diamidino-2-phenylindole (DAPI; Invitrogen). Cells were sorted into chilled staining buffer and used either for RNA isolation or cell culture. The purity of the sorted cell populations was verified directly after sorting as .95%. For flow cytometric analysis of cultured cells, monolayers were washed with PBS, detached by treatment with TrypLE w (Invitrogen), washed and stained as described above. After incubation cells were washed in staining buffer and analyzed using FACSAria I or LSR II systems.
Intracellular staining of Ki-67 in fibroids (n ¼ 5) was conducted after staining of surface markers. Cells were fixed in freshly prepared high-grade 2% neutral buffered formalin (Electron Microscopy Science, Munich, Germany) for 20 min at room temperature (RT). Cells were washed and stained with anti-Ki-67 in permeabilization buffer (HBSS, 1% BSA; 10 mM HEPES, 0.5% Saponine) for 40 min at RT. After repeated washings, cells were analyzed and 100 000 events were recorded.
Cytogenetic analysis and DNA sequencing
For correlation analysis a total of 26 fibroids previously analyzed for cytogenetic aberrations or mutations in the MED12 locus were used (see Supplementary data, Table SI ). Cytogenetic characterization was performed The CD24 hi smooth muscle subpopulation from cell cultures following routine techniques as described (Klemke et al., 2009) . As a rule, G-bands (GTG) were analyzed based on a resolution of at least 300 bands/haploid set. If necessary, further characterization was performed by fluorescent in situ hybridization (FISH) using three bacterial artificial chromosome clones located distal (3 ′ ) and proximal (5 ′ ), respectively, of the high mobility group AT-hook (HMGA)2 locus as break-apart probe. Probe labeling was performed by nick translation either with SpectrumOrange-dUTP or SpectrumGreen-dUTP (Abbott Molecular, Wiesbaden, Germany). Fifteen microliters of the break-apart probe (concentration: 100 ng/ml) was used per slide. Co-denaturation was performed on a ThermoBrite (Abbott Molecular) for 5 min at 858C followed by overnight hybridization in a humidified chamber at 378C. Post-hybridization was performed at 428C for 2 min in 0.4 × SSC/0.3% NP-40. Interphase nuclei were counterstained with DAPI (0.75 mg/ml). Slides were examined with an Axioskop 2 plus fluorescence microscope (Carl Zeiss, Gö ttingen, Germany); images of 100 non-overlapping nuclei were captured with a high performance CCD-camera (Visitron Systems, Puchheim, Germany) and edited with FISH View (Applied Spectral Imaging, Migdal HaEmek, Israel).
MED12 mutations from fresh-frozen tumors were identified by DNA sequencing of amplified DNA as described (Markowski et al., 2012) . For PCR amplifications 1 mg of genomic template DNA were used. Primers used to amplify the desired PCR fragment of the genomic template DNA were 5 ′ -CCC CTT CCC CTA AGG AAA AA-3 ′ (forward) and 5 ′ -ATG CTC ATC CCC AGA GAC AG-3 ′ (reverse) (Markowski et al., 2012) . PCR-products were purified by agarose gel-electrophoresis to remove primers and dNTPs and the desired DNA-fragment/-band was extracted by a QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) using a QIACube. DNA sequencing of the purified PCR-products was performed by GATC Biotech (GATC Biotech, Konstanz, Germany).
Isolation of RNA, reverse transcriptionpolymerase chain reaction and quantitative real-time PCR
Isolation of RNA from sorted cells and frozen tissue was performed using RNeasy Micro Kit w and RNeasy Mini Kit w (Qiagen), respectively, according to the manufacturer's instructions. Reverse transcription was carried out using the High Capacity cDNA reverse Transcription Kit (Applied Biosystems, Darmstadt, Germany). cDNA from sorted cells was preamplified using the Taqman w PreAmp Master Mix (Applied Biosystems) according to manufacturer's protocol. Relative quantification was carried out by realtime PCR analysis using the Applied Biosystem 7500 HT Fast PCR system using commercially available gene expression assays (Applied Biosystems) and designed primer pairs listed in Table II . Quantification was performed referring to the expression of the housekeeping gene HPRT, which turned out to be expressed steadily in our experiments. 
Hypoxanthine phosphoribosyltransferase 1 (HPRT1) Hs02800695_m1 NM_000194
.35 were excluded from analysis because expression levels are assumed to be out of accurate range.
Immunostaining and histological analysis
Immunostaining of cells and tissue was performed with antibodies listed in Table I . Before staining procedure specimens were treated as follows: formalin fixed, paraffin embedded (FFPE)-tissue was deparaffinized and underwent antigen retrieval with 'antigen retrieval solution pH 6 ′ (DAKO, Glostrup, Denmark). Cryosections (6 mm) were immediately fixed in ice-cold acetone prior staining. Immunostaining of cells was performed on chamber slides (Nunc, Rosklide, Denmark) after fixation with freshly prepared 2% formalin (ElectronMicroscopyScience) for 15 min and permeabilization with ice-cold acetone for 5 min at 2208C. Before staining all specimens were washed with Tris-buffered saline (TBS; Medicago, Uppsala, Sweden) pH 7.4 and incubated with blocking buffer consisting of TBS supplemented with 0.05% Tween-20, 3% skimmed milk powder, 1% BSA, 0.1% fish gelatine (all from Sigma, Taufkirchen, Germany) for at least 30 min. Antibodies were incubated for 1 h or overnight in blocking buffer. After washing secondary antibodies [anti-mouse IgG-Alexa555 conjugate (Invitrogen) or anti-rabbit-Dylight488 conjugate (Pierce, Bonn, Germany)] were applied at a concentration of 5 mg/ml for 1 h. Cells were counterstained with DAPI and observed under an Axioscop 2 inverted microscope equipped with a mercury arc lamp and appropriate filter sets (Zeiss, Jena, Germany). Background fluorescence was determined by applying the secondary conjugated antibody alone and by replacement of the primary antibody with mouse ore rabbit IgG-fraction (Dianova, Hamburg, Germany). Isotype controls were matched to antibody concentration or used at 5 mg/ml if primary antibody concentration was unknown. CD24 in tumors and xenografts was visualized by immunoperoxidase-DAB method using the EnVision anti-mouse staining kit (DAKO) according to manufacturer's protocol. Hematoxylin for nuclear counterstain was from Sigma and used according to manufacturer's manual.
Data analysis
Flow cytometric data were analyzed using FlowJo 8.7.3 software. Pearson's correlation was performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, USA). P-value was calculated using the unpaired Student's t-test with 95% confidence intervals. P-value of ,0.05 were considered statistically significant.
Results
Uterine fibroid tissue is highly enriched for CD24 hi cells
Since gene expression studies revealed a strong expression of CD24 in fibroid tissue (unpublished data), we evaluated differences on a single cell level by comparative flow cytometric analysis. Single cell suspensions of fibroid and myometrial tissue were stained with an antibody directed against CD24 and exclusion markers. Tissue derived non-endothelial, non-leukocyte (CD31-/CD45-) cells divided into two distinct populations designated CD24 lo and CD24 hi based on their CD24 expression (Fig. 1A) . Comparison of both tissues revealed a consistently and significantly higher frequency of CD24 hi cells in fibroids than in myometrium (63% + 19% versus 16 + 7% of viable CD24 hi /CD31-/ CD45-cells; P , 0.005; n ¼ 9 fibroids, n ¼ 4 myometrium; Fig. 1B ). Compared to fibroids, preparations from myometrial tissue from four patients showed a significantly higher infiltration of endothelial cells (CD 31 + 10 + 8% versus 5 + 2%, P , 0.05) and a not significantly higher amount of leukocytes (CD 45 + 19 + 15% versus 11 + 9%), probably caused by a stronger vascularization of the myometrial tissue (for detailed frequency of subpopulations see Supplementary data, Fig. S1 ).
CD24 hi cells are organized in clusters and have a smooth muscle phenotype
To correlate the high abundance of CD24 hi cells with the pathophysiology of fibroids, the localization of CD24 within myometrial and fibroid tissue was determined by immunohistochemistry. Fibroid tissue showed a pattern of CD24 positive cells organized in clusters interspersed by unstained cells (Fig. 1C) . Vice versa, CD24 positive cells were only sparsely detected in myometrium. Higher magnification showed that the stained cells had fusiform, spindle-shaped morphology.
To confirm these observations, we also performed staining of fibroid and myometrial cryosectioned tissue with the antibody ML-5 which detects a formalin-sensitive epitope within the core protein of CD24 (Kristiansen et al., 2010) . Regardless of some minor impacts in morphology and staining intensity caused by using cryosections, we were able to reproduce the myoma specific staining of CD24 with this antibody (Supplementary data, Fig. S2A and B). Normal tonsil tissue used as positive control showed strong staining of CD24 in the squamous epithelium layer and mantle zone of lymph follicles (Supplementary data, Fig. S2C ) as reported elsewhere (Barcos et al., 1986; Sano et al., 2009) . To verify a smooth muscle differentiation, double staining of smooth muscle actin (SMA) and CD24 was performed. CD24 and SMA showed apparent co-localization (Fig. 1D) , indicating a smooth muscle-like differentiation of CD24 expressing cells.
CD24 hi cells show a reduced proliferation rate in vivo
Because it is unclear how CD24 hi cells enrich in fibroids, we looked for different proliferation by the determination of Ki-67 positive cells within the fibroid subpopulations ( Fig. 2A) . Ki-67 is only present in cycling cells, whereas dormant or quiescent G 0 cells are negative for this marker (Scholzen and Gerdes, 2000) . The overall frequency of Ki-67+ cells in fibroid cell preparations was quite low (1.6 + 0.8%; n ¼ 5) (data not shown) which is consistent with previous findings (Kawaguchi et al., 1991; Bourlev et al., 2003; Pavlovich et al., 2003) . However, Ki-67 staining was mostly found in CD24 lo cells (3.6 + 2.9%). The CD24 hi subfraction showed 14-fold lower frequency of Ki-67+ cells (0.3 + 0.2% P , 0.05, n ¼ 5) (Fig. 2B ). This low percentage of proliferative cells indicates that CD24 hi cells might reflect a quiescent subpopulation which will not enrich in tumors due to enhanced proliferation.
Additional stem cell markers are present on CD24 hi cells showed enlarged morphology of CD24 hi cells, whereas CD24 lo cells had a more compact shape (Fig. 4A, b and f) . Immunocytochemical staining of CD24 confirmed the purity of the sorted cells as strong CD24 staining was detectable in CD24 hi but absent in CD24 lo sorted cells (Fig. 4A, c and g). To check if both subsets are composed of cells with smooth muscle phenotype subpopulations were seeded and stained for SMA. After the day of seeding (Day 0) CD24 hi cells showed only a moderate staining of aSMA whereas CD24 lo cells exhibited a staining with stronger intensity. After cultivation for 7 days both subpopulations were entirely positive for aSMA (Fig. 4B) . Determination of Ki-67 index by flow cytometry after 7 days of culture revealed that the overall frequency of Ki-67-positive cells increased in both subpopulations compared with initial levels at isolation. However, the CD24 hi cells were still less positive for Ki-67 when compared with CD24 lo cells (CD24 hi 17% + 11 versus CD24 lo 53% + 16; n ¼ 3, P , 0.5; Supplementary data, Fig. S3 ).
The expression of CD24 is diminished upon in vitro culture
Since there was no difference in aSMA protein expression between CD24 hi and CD24 lo cells after 7 days of in vitro culture, we were interested to see if both subpopulations retain their CD24 phenotype when expanded in vitro. Sorted and mixed cells were cultured for 7 days and reanalyzed for their CD24 expression. Analysis of unsorted cells revealed that after in vitro expansion initial differentiation between CD24 lo and CD24 hi subpopulations was absent. Instead, only one population with low CD24 expression comparable with that of initially identified CD24 lo cells was observed (Fig. 5A) . In accordance, sorted and 1 week cultured CD24 hi cells showed a strongly reduced expression of CD24 compared with initial mean fluorescent intensity levels and expression was nearly absent after 3 weeks of culture (data not shown). Hence, in vitro culture reduced the phenotypic difference between the subpopulations probably by influencing cellular differentiation.
The CD24 hi subfraction is detectable in xenografts
Fibroid xenografts can only be generated from freshly dissociated tumor cells, whereas in our hands cultured cells did not give rise to stable xenografts (Drosch et al., 2013) . Since CD24 expression is lost upon in vitro culture it can be hypothesized that reduced expression might be correlated with a loss of tumorigenicity. To address this question, we characterized xenografts for the presence of CD24-positive cells at two time points after transplantation. Immunostaining of sectioned xenografts displayed moderate presence of CD24 hi cells 1 week post-injection ( Fig. 5B and C, left) . Although co-staining with Ki-67 revealed that CD24 cells were negative for this proliferation marker, a close proximity between CD24 lo and Ki-67 positive was noted (Fig. 5B) . After 4 weeks of tumor growth 50% of the cells were positive for CD24 (Fig. 5C, right) which is comparable to the frequency found in human primary fibroids.
The CD24 hi subpopulation has an immature phenotype
We further analyzed mRNA derived from both subpopulations by quantitative real-time PCR (qRT -PCR) to confirm the observed phenotypes (Fig. 6) . We checked the expression levels of aSMA, b-catenin and CD24 expression in fibroids is independent of tumor size or age but correlates with WNT4 expression in a certain genetic subgroup
Since recently fibroids have been shown to belong to different genetic subgroups showing mutually exclusive mutations in the MED12 gene or HMGA2 (Markowski et al., 2012) , we were interested to analyze if CD24 expression could be correlated to one of these subgroups. qRT-PCR analysis of mRNA derived from fibroids showing either MED12 mutations (n ¼ 16) or HMGA-rearrangements (n ¼ 10) revealed that CD24 is highly expressed on both genetic subgroups. Besides this we also analyzed if the wingless-type MMTV integration site family, member 4 (Wnt4) which has been shown to be significantly higher expressed in fibroids with MED12 mutation (Markowski et al., 2012) also correlates with CD24 expression. A significant correlation (P , 0.05, n ¼ 16) was observed between CD24 and Wnt4 only in tumors with mutations in the MED12 gene (Fig. 7A ) including base exchanges of codon 43 and 44 which are the most frequent MED12 mutations in fibroids (Mäkinen et al., 2011) . In turn, fibroids with 12q14-15 rearrangements (Fig. 7B ) did not exhibit this correlation between the expression of CD24 and Wnt4 in n ¼ 8 tumors (WNT4 signal was not detectable in 2/10 tumors). CD24 expression did not correlate with tumor size or patient age in tumors in both groups (data not shown; please note also Supplementary data, Table SI for further details).
Discussion
Based on the identification of SP cells in fibroid and myometrial tissue, myomagenesis can be considered as the result of dysregulated stem/ and CD106 were mostly indifferent between subpopulations. Isotype controls were IgG1 and IgG2a, respectively.
progenitor cells (Ono et al., 2007 (Ono et al., , 2012 Mas et al., 2012) . Our study strongly substantiates the concept of a 'dysregulated progenitor hypothesis' by the identification of a certain cellular subpopulation in uterine fibroids characterized by the abundant expression of the surface marker CD24. We were able to show that this surface protein is strongly expressed on a subset of cells in fibroid tissue. Although CD24 cannot be considered being an unequivocal stem cell marker (Al-Hajj et al., 2003; von Furstenberg et al., 2011) , this protein tends to be mostly expressed on undifferentiated or progenitor cells or tumor-initiating cells in different malignancies (Lim 2005; Fang et al., 2010; Lee et al., 2011) . As uterine fibroids are considered to arise from a single cell clone (HoldsworthCarson et al., 2013) , it is tempting to speculate that CD24 hi cells are derived from a transformed and mutated myometrial stem/progenitor cells possibly being also positive for CD24. We could not provide direct evidence for enhanced self-renewal or in vivo tumor-regeneration which are considered to be main features of stem cells (Gonzales and Bernad, 2012) because this would be dependent on the cells' ability to be propagated extensively in vitro. This is hampered by the very short in vitro lifespan of MED12-mutated cells (Markowksi et al., 2014) and an almost subsequent activation of senescence pathways upon culture (Markowski et al., 2010) as well as the inability of fibroid cells to grow in soft-agar (Drosch et al., 2013) . Nevertheless, CD24 hi cells exhibit certain features also observed in progenitor cells. Akin to stem cell-like SP cells isolated from myometrium and fibroids (Ono et al., 2007 (Ono et al., , 2013 CD24 hi cells showed a significantly reduced expression of differentiation markers such as aSMA and a quiescent G 0 state as indicated by the absence of Ki-67 in CD24 hi cells. Interestingly, xenografts generated from primary fibroid cells showed a high proportion of CD24 hi cells. Although these cells were negative for Ki-67 they were still detectable after prolonged tumor growth suggesting that CD24 hi cells persist as immature progenitor-like cells within in the tumors. This assumption is further supported by the reduced expression of CD90 which is believed to be a marker of terminally differentiated fibroid cells (Chang et al., 2010) . In turn, strong expression of the MSC marker CD73 (Dominici et al., 2006) was revealed in CD24 hi cells using both flow cytometry and qRT -PCR. As this is an additional feature shared with the SP cells isolated by the Hoechst efflux method (Mas et al., 2012) , we consider a certain overlap between both phenotypes. However, the high abundance of the CD24 hi population in fibroid tissue in comparison to the fibroid SP makes it more likely that those cells could reflect some intermediate progenitor cells rather than infrequent early stem cells. In contrast to freshly isolated cells, in vitro cultured CD24 hi cells showed a phenotypic change with increased aSMA staining and reduced expression of CD24. This is in accordance with observations made by several other groups describing loss of hormone receptors (Severino et al., 1996; Gargett et al., 2002) or massive changes in gene expression profile also confirming a significant down-regulation of CD24 in cultured fibroid cells (Zaitseva et al., 2006) . Interestingly, the authors from the previously study by Chang et al. (2010) observed that less differentiated CD90 2 fibroid cells (which we found out to be CD24 hi ) shift to terminally differentiated CD90 + cells following in vitro culture. In general, not only differentiation/dedifferentiation upon culture but also a selection against MED12 mutated cells (Markowski et al., 2014) may account for some of the above observations. Hence, it seems to be conceivable that similarly CD24 hi cells could be replaced by differentiated CD24 lo cells. Based on this assumption, it can be hypothesized that loss of CD24 expression might also correlate with the loss of in vivo growth capacity of fibroid cells. Indeed, cultured-and therefore CD24 lo cellsare unable to form stable xenografts (Drosch et al., 2013) . Myometrial cells, which we determined to be mostly CD24 lo , are also unable to form tumors after injection (Suo et al., 2009; Drosch et al., 2013 it is rather unlikely that these cells will enrich due to hyperproliferation. A possible scenario for enrichment could be that an altered, potentially blocked differentiation towards CD24 lo cell leads to accumulation of CD24 hi cells. This hypothesis is supported by a recently identified mutation present in almost 70% of all fibroids (Mäkinen et al., 2011) , i.e. affecting the gene encoding for the Mediator complex subunit 12 (MED12). MED12 is considered to be involved in regulating stem cell function and embryonic development (Tutter et al., 2009) . Fibroids carrying MED12 mutations show alterations in the canonical WNT-signaling pathway (Mäkinen et al., 2011) which in turn facilitates stem cell differentiation and self-renewal via downstream targets such as b-catenin (Clevers, 2006) . b-catenin itself is known to cause fibroid-like lesions after uterus-specific overexpression in a mouse model ( Tanwar et al., 2009) . Intriguingly, we found a significantly positive correlation between the expression of CD24 and one of the WNTpathway members, WNT4, in tumors with MED12 mutation whereas tumors with HMGA2-rearrangements did not exhibit any correlation. As we also observed that CD24 hi cells tend to show a higher expression of b-catenin. Besides an involvement in paracrine mechanisms (Ono et al., 2013) shows certain properties also common in progenitor cells. These cells might enrich in fibroid tissue due to altered differentiation and erroneous control mechanisms. The further characterization of this fibroid subpopulation and its origin will contribute to a better understanding of fibroid pathophysiology and might open up possibilities for the development of new treatment strategies.
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